Aspiriant LLC’s Linde LIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$582K Buy
1,226
+248
+25% +$122K 0.01% 225
2026
Q2
$508K Buy
978
+467
+91% +$237K 0.01% 244
2026
Q1
$253K Sell
511
-58
-10% -$27.4K 0.01% 305
2025
Q4
$243K Buy
569
+60
+12% +$25.7K 0.01% 298
2025
Q3
$242K Sell
509
-63
-11% -$29.8K 0.01% 275
2025
Q2
$268K Sell
572
-20
-3% -$9.13K 0.01% 271
2025
Q1
$276K Sell
592
-49
-8% -$22.1K 0.01% 246
2024
Q4
$268K Buy
641
+121
+23% +$55.1K 0.01% 247
2024
Q3
$248K Sell
520
-1
-0.2% -$456 0.01% 254
2024
Q2
$229K Sell
521
-316
-38% -$139K 0.01% 260
2024
Q1
$389K Sell
837
-161
-16% -$69.7K 0.02% 220
2023
Q4
$410K Sell
998
-28
-3% -$11K 0.02% 208
2023
Q3
$382K Buy
1,026
+18
+2% +$6.85K 0.02% 202
2023
Q2
$384K Sell
1,008
-385
-28% -$141K 0.02% 197
2023
Q1
$495K Sell
1,393
-3
-0.2% -$1K 0.03% 176
2022
Q4
$455K Buy
1,396
+286
+26% +$89.6K 0.02% 183
2022
Q3
$299K Sell
1,110
-21
-2% -$6.03K 0.01% 211
2022
Q2
$326K Buy
1,131
+6
+0.5% +$1.87K 0.02% 203
2022
Q1
$360K Sell
1,125
-42
-4% -$13K 0.02% 203
2021
Q4
$405K Buy
+1,167
New +$378K 0.02% 194
2019
Q3
– Sell
-1,448
Closed -$289K – 226
2019
Q2
$289K Sell
1,448
-353
-20% -$66K 0.02% 183
2019
Q1
$319K Sell
1,801
-821
-31% -$136K 0.03% 175
2018
Q4
$407K Buy
+2,622
New +$414K 0.03% 156

Other funds holding LIN

Aspiriant LLC's LIN Position: Q3 2026 in Review

Aspiriant LLC increased its Linde (LIN) stake by 25% in Q3 2026, buying an estimated $122K and bringing the position to 1,226 shares worth $582K. The position accounts for 0.01% of the portfolio, ranked #225.

Aspiriant LLC first reported a position in LIN in Q4 2018 and has held it in 23 quarters since. 606 funds tracked by Wall St. Rank hold LIN as of Q3 2026.

  • Aspiriant LLC held 1,226 shares of Linde worth $582K as of Q3 2026.
  • Aspiriant LLC bought 248 Linde shares in Q3 2026, an estimated $122K.
  • Linde made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #225 holding.
  • Aspiriant LLC first reported a position in Linde in Q4 2018 and has held it in 23 quarters since.
  • 606 funds tracked by Wall St. Rank held Linde as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.